Relief Therapeutics Holding SA (RLFTY)
OTCMKTS · Delayed Price · Currency is USD
3.320
0.00 (0.00%)
At close: Aug 19, 2025
RLFTY Market Cap
RLFTY has a market cap or net worth of $42.41 million as of August 22, 2025. Its market cap has increased by 160.75% in one year.
Market Cap
42.41M
Enterprise Value
29.17M
Revenue
5.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
$3.32
Market Cap Chart
Since July 19, 2016, RLFTY's market cap has decreased from 93.95M to 42.41M, a decrease of -54.86%. That is a compound annual growth rate of -8.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 42.41M | -27.14% |
| Dec 30, 2024 | 58.21M | 96.41% |
| Dec 29, 2023 | 29.64M | -79.23% |
| Dec 30, 2022 | 142.71M | -52.45% |
| Dec 30, 2021 | 300.10M | -69.64% |
| Dec 30, 2020 | 988.40M | 45,169.87% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 19, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 832.17M |
| Glass House Brands | 633.65M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 594.33M |
| CytoDyn | 363.56M |
| American Oncology Network | 355.44M |
| Northwest Biotherapeutics | 352.80M |